Efficacy and Safety of Daratumumab, Lenalidomide and Dexamethasone Therapy in the First Relapse of Multiple Myeloma Patients - Real World Data from Hungary. [PDF]
J HematolLovas S +10 more
europepmc +1 more source
Daratumumab Treatment for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): A Case Report. [PDF]
Ann Clin Transl NeurolZhang X +8 more
europepmc +1 more source
Outcomes of patients with systemic light chain amyloidosis treated with DVD front-line therapy. [PDF]
CardiooncologyWang J +11 more
europepmc +1 more source
Why We Do Not Recommend That People With High-Risk Smoldering Myeloma Receive Treatment. [PDF]
Am J HematolMohyuddin GR +3 more
europepmc +1 more source
Cluster of differentiation 38 monoclonal antibody therapy in the treatment of multiple myeloma: a systematic review and meta-analysis. [PDF]
Front PharmacolGuo YJ, Tian ZZ, Zhang XF, Zhu ZJ.
europepmc +1 more source
Serological and Clinical Evaluation of Incompatible Crossmatches Encountered in Pre-transfusion Testing. [PDF]
CureusBadoni A, Kusum A, Raturi M.
europepmc +1 more source
Daratumumab-induced acute angle closure glaucoma: bone marrow transplantation as a possible risk factor and atropinization as a potential solution [PDF]
Cansu Yüksel Elgin +3 more
openalex +1 more source
Advances in the pathophysiology and treatment of anaemia in multiple myeloma. [PDF]
Curr Opin HematolGiuliani N +2 more
europepmc +1 more source
Ablation of CD38 in multiple myeloma cells leads to an aggressive phenotype in a mouse xenograft model. [PDF]
Blood AdvDyer MR +14 more
europepmc +1 more source